How much funding has Signatur Biosciences raised?

Signatur Biosciences has raised $7.0M in total funding, most recently a Seed round.

Who are Signatur Biosciences's investors?

Signatur Biosciences's investors include The Discovery Lab (IBA), Noshaq, Y Combinator Continuity Fund.

When was Signatur Biosciences founded?

Signatur Biosciences was founded in 2022.

Where is Signatur Biosciences headquartered?

Signatur Biosciences is headquartered in London, United Kingdom.

What industry is Signatur Biosciences in?

Signatur Biosciences operates in Biotech, Diagnostics, Healthcare.

How many employees does Signatur Biosciences have?

Signatur Biosciences has 1-10 employees.

Signatur Biosciences

Simple tests for complex diseases.

London, United Kingdom · Founded 2022 · $7.0M raised

Biotech

Diagnostics

Healthcare

YC S22

Headquarters: London
Employees: 1–10
Founded: 2022
Website: signatur.bio

Total Funding: $7.0M
Last Round: $7.0M SeedMay 2025
Rounds: 1

About

We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.

Summary

Signatur Biosciences is a Biotech company based in London, United Kingdom, founded in 2022. It has raised $7.0M in total across 1 round, most recently a $7.0M Seed round in May 2025. Investors include The Discovery Lab (IBA), Noshaq and Y Combinator Continuity Fund.